Pilot Study for Peripheral Neuromuscular Electrical Stimulation of the Quadriceps Muscle

Sponsor
University of Sao Paulo General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05888714
Collaborator
Agência Brasileira de Desenvolvimento Industrial (Brazilian Agency For Industrial Development) (Other)
15
1
4
7
2.1

Study Details

Study Description

Brief Summary

Feasibility study of a new medical device that will evaluate the usability and effectiveness of a cycle ergometer device associated with neuromuscular electrical stimulation (FES cycling). The study's objective is to evaluate the effect of the application of functional electrical stimulation of the new device on participants' quadriceps muscle strength in comparison to a medical device with similar characteristics and to a control group. Secondarily, the study will compare the usability of the two medical devices as evaluated by the participants and the therapists who apply the treatment, as well as the participants' satisfaction with the treatment, identifying possible adverse effects.

Condition or Disease Intervention/Treatment Phase
  • Device: Experimental FES cycling
  • Device: Comparator FES cycling
  • Other: Conventional physical therapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Parallel AssignmentParallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot Study for Peripheral Neuromuscular Electrical Stimulation of the Quadriceps Muscle: Healthy or Deprived of Central Nervous System Control
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental FES cycling

New medical device combining cycle ergometer use and neuromuscular electrical stimulation (FES cycling)

Device: Experimental FES cycling
Using the experimental, new FES cycling device, provide neuromuscular electrical stimulation of the gluteal, quadriceps and hamstring muscles at sufficient intensity to cause muscle contraction and push the cycle ergometer pedals for 30 minutes, for 16 treatment sessions (twice a week, for 8 weeks), in addition to conventional physical therapy for muscle strengthening.

Active Comparator: Comparator FES cycling

Existing medical device combining cycle ergometer use and neuromuscular electrical stimulation (FES cycling)

Device: Comparator FES cycling
Using the comparator, marketed FES cycling device, provide neuromuscular electrical stimulation of the gluteal, quadriceps and hamstring muscles at sufficient intensity to cause muscle contraction and push the cycle ergometer pedals for 30 minutes, for 16 treatment sessions (twice a week, for 8 weeks), in addition to conventional physical therapy for muscle strengthening.

Active Comparator: Conventional physical therapy

Conventional physical therapy.

Other: Conventional physical therapy
Conventional physical therapy for muscle strengthening, for 16 treatment sessions (twice a week, for 8 weeks).

No Intervention: Operators

Operators will evaluate systems usability during interventions.

Outcome Measures

Primary Outcome Measures

  1. Change in knee joint extensors peak torque (Newton-Meters) [Change from baseline knee joint extensors peak torque at end of intervention, completed 8 weeks after initiation]

    Quadriceps muscle strength, measured by isokinetic dynamometry

  2. Change in knee joint flexors peak torque (Newton-Meters) [Change from baseline knee joint flexors peak torque at end of intervention, completed 8 weeks after initiation]

    Quadriceps muscle strength, measured by isokinetic dynamometry

  3. Change in thigh perimeter (centimeters) [Change from baseline thigh perimeter at end of intervention, completed 8 weeks after initiation]

    Quadriceps muscle integrity, measured by thigh volumetry

  4. Change in rectus femoris thickness (centimeters) [Change from baseline rectus femoris thickness at end of intervention, completed 8 weeks after initiation]

    Rectus femoris muscle structural integrity, measured by ultrasound

  5. Change in vastus intermedius thickness (centimeters) [Change from baseline vastus intermedius thickness at end of intervention, completed 8 weeks after initiation]

    Vastus intermedius muscle structural integrity, measured by ultrasound

Secondary Outcome Measures

  1. System Usability Score [System usability at end of intervention, completed 8 weeks after initiation]

    Systems usability, measured by self-referred survey (0-100, the higher the score, the better the outcome)

  2. Patients Perception of Treatment Outcomes Score [Patients perception of treatment outcomes at end of intervention, completed 8 weeks after initiation]

    Satisfaction, measured by self-referred survey (6-30, the higher the score, the better the outcome)

  3. Adverse effects inventory [Adverse effects at end of each treatment session with the assigned intervention, completed 30min after session initiation]

    Qualitative evaluation of adverse effects, if any

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Spinal cord injury, brain injury or acquired muscle weakness

  • Managed chronic diseases

  • No contraindications to the practice of physical exercise

  • Ability to communicate in oral and written Portuguese

Exclusion Criteria:
  • Amputation of lower limbs at any level

  • Unstable or acute fractures of lower limbs

  • Contraindication for the practice of physical activity

  • Open wounds in the lower limbs

  • Consent withdraw

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto de Medicina Física e Reabilitação, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo São Paulo SP Brazil 04116-030

Sponsors and Collaborators

  • University of Sao Paulo General Hospital
  • Agência Brasileira de Desenvolvimento Industrial (Brazilian Agency For Industrial Development)

Investigators

  • Principal Investigator: Linamara R. Battistella, MD, PhD, University of Sao Paulo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier:
NCT05888714
Other Study ID Numbers:
  • CAAE 64324122.0.0000.0068
First Posted:
Jun 5, 2023
Last Update Posted:
Jun 5, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 5, 2023